Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
Delgocitinib cream, Cream Vehicle
LEO Pharma A/S
Mild to severe palmoplantar pustulosis
1 trial -
Demcizumab
Mereo BioPharma Group plc
Pancreatic Cancer
2 trials -
Dendritic Cell Vaccination
Quantum Biopharma
Breast Cancer
1 trial -
Derazantinib
Basilea Pharmaceutica
Gastric Adenocarcinoma
1 trial -
Description and Composition of the Placebo • Placebo oil solution matching the Cannabis Extract Avextra 10/10 Solution. • Pharmaceutical form: solution (oil) • Route of administration: oral • Storage: Store tightly closed below 25°C and protected from light like the verum form. • Country of origin: Italy., Cannabis Extract Avextra 10/10 Solution
Fondazione Telethon ETS
Patients with advanced oncologic disease receiving active treatment with WHO level II or III opioids and adjuvants therapies
1 trial -
Deutetrabenazine 6 MG
Teva Pharma GmbH
Dystonia, Primary
1 trial -
Dexamethasone 4 mg tablets, Cytarabine 20 mg/ml Solution for Injection or Infusion, Calquence 100 mg hard capsules, Cyclophosphamide 500 mg Powder for Solution for Injection or Infusion, Fludarabine phosphate 25 mg/ml Concentrate for Solution for Injection or Infusion, Histergan Tablets, Tecartus 0.4 - 2 x 10e8 cells dispersion for infusion, Mesna Injection, Methylprednisolone 1000 mg powder and solvent for solution for injection/infusion, RoActemra 20 mg/mL concentrate for solution for infusion, Panadol 50
Lacuna Pharma Pty Ltd
Relapsed/Refractory Mantle Cell Lymphoma
1 trial -
Dexamethasone phosphate 4 mg/ml solution for injection/infusion, Paracetamol 500 mg Film-Coated Tablets, Diluent for REGN5458, Linvoseltamab, Diphenhydramine Hydrochloride 25 mg Tablets, Dermodrin 30 mg/2 ml soluție injectabilă, Dexamethasone 4 mg tablets, RoActemra 20 mg/mL concentrate for solution for infusion, Linvoseltamab
Lacuna Pharma Pty Ltd
Relapsed or Refractory Multiple Myeloma
1 trial -
Diagnóstico prick Dermatophagoides farinae 40 HEP/ml, Diagnóstico prick control positivo, Diagnóstico prick Dermatophagoides pteronyssinus 40 HEP/ml, Diagnóstico prick control negativo
Lacuna Pharma Pty Ltd
Allergies
1 trial -
Diagnóstico prick control positivo, Diagnóstico prick Olea Europae, Diagnóstico prick control negativo, Diagnóstico prick Olea Europae, Diagnóstico prick Olea Europae, Diagnóstico prick Olea Europae
Lacuna Pharma Pty Ltd
Allergies
1 trial -
Diagnóstico prick control positivo, Dignostico prick Blomia tropicalis, Diagnóstico prick Blomia tropicalis, Diagnóstico prick Blomia tropicalis, Diagnóstico prick Blomia tropicalis, Diagnóstico prick control negativo
Lacuna Pharma Pty Ltd
Allergies
1 trial -
Diuretics
Rhythm Pharmaceuticals Netherlands B.V.
Heart Failure
1 trial -
Dociparstat sodium
Jazz Pharmaceuticals Ireland Limited
Acute Myeloid Leukemia
1 trial -
Dordaviprone (ONC201)
Jazz Pharmaceuticals Ireland Limited
Glioblastoma
1 trial -
Dordaviprone (ONC201)
Jazz Pharmaceuticals Ireland Limited
Endometrial Cancer Recurrent
1 trial -
Dordaviprone (ONC201)
Jazz Pharmaceuticals Ireland Limited
Glioma
1 trial -
Dose 1 of BMN 331
BioMarin Pharmaceutical Australia Pty Ltd
Hereditary Angioedema
1 trial -
Dream01, IMATINIB
Pari Pharma GmbH
SCD severe patients
1 trial -
Drug Omega 3
Matinas BioPharma Holdings
Hypertriglyceridemia
1 trial -
Dupilumab
CATALYST PHARMACEUTICALS, INC.
COVID-19
1 trial -
Durvalumab
Syndax Pharmaceuticals
Unresectable Intrahepatic Cholangiocarcinoma
1 trial -
E004 (epinephrine inhalation aerosol), 90 mcg/actuation
Amphastar France Pharmaceuticals
Asthma
1 trial -
E6005
Organon Pharma Pty Ltd
Atopic Dermatitis
1 trial -
EDP-235
ENANTA PHARMACEUTICALS INC
COVID-19
3 trials
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources